These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

301 related articles for article (PubMed ID: 32598582)

  • 1. [Evolution of pathogenetic therapy of pulmonary arterial hypertension].
    Chazova IE; Yarovoy SY; Danilov NM
    Ter Arkh; 2019 Dec; 91(12):4-9. PubMed ID: 32598582
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeted therapies in pulmonary arterial hypertension.
    Montani D; Chaumais MC; Guignabert C; Günther S; Girerd B; Jaïs X; Algalarrondo V; Price LC; Savale L; Sitbon O; Simonneau G; Humbert M
    Pharmacol Ther; 2014 Feb; 141(2):172-91. PubMed ID: 24134901
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Management of Pulmonary Arterial Hypertension.
    Weatherald J; Varughese RA; Liu J; Humbert M
    Semin Respir Crit Care Med; 2023 Dec; 44(6):746-761. PubMed ID: 37369218
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prostaglandin and prostaglandin receptors: present and future promising therapeutic targets for pulmonary arterial hypertension.
    Zeng C; Liu J; Zheng X; Hu X; He Y
    Respir Res; 2023 Nov; 24(1):263. PubMed ID: 37915044
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Endothelin receptor antagonists for pulmonary arterial hypertension.
    Liu C; Chen J
    Cochrane Database Syst Rev; 2006 Jul; (3):CD004434. PubMed ID: 16856046
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evidence-based pharmacologic management of pulmonary arterial hypertension.
    Benedict N; Seybert A; Mathier MA
    Clin Ther; 2007 Oct; 29(10):2134-53. PubMed ID: 18042471
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel strategies for treatment of pulmonary arterial hypertension.
    Jasińska-Stroschein M; Orszulak-Michalak D
    Postepy Hig Med Dosw (Online); 2017 Jul; 71(0):577-588. PubMed ID: 28791952
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Update on pulmonary arterial hypertension pharmacotherapy.
    Velayati A; Valerio MG; Shen M; Tariq S; Lanier GM; Aronow WS
    Postgrad Med; 2016 Jun; 128(5):460-73. PubMed ID: 27232660
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Targeted therapy for pulmonary arterial hypertension in patients without comorbidities].
    Klose H; Harbaum L; Richter MJ; Lichtblau M; Marra AM; Kabitz HJ; Harutyunova S; Milger-Kneidinger K; Lange TJ
    Pneumologie; 2023 Nov; 77(11):890-900. PubMed ID: 37963478
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Drug therapy of pulmonary arterial hypertension in 2014].
    Aschermann M; Jansa P
    Vnitr Lek; 2014 Apr; 60(4):282-8. PubMed ID: 24985985
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pulmonary arterial hypertension : a comprehensive review of pharmacological treatment.
    Berman Rosenzweig E; Barst RJ
    Treat Respir Med; 2006; 5(2):117-27. PubMed ID: 16512692
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recent strategies in treatment of pulmonary arterial hypertension, a review.
    Fallah F
    Glob J Health Sci; 2015 Jan; 7(4):307-22. PubMed ID: 25946920
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Medical therapies for pulmonary arterial hypertension.
    Pulido T; Zayas N; de Mendieta MA; Plascencia K; Escobar J
    Heart Fail Rev; 2016 May; 21(3):273-83. PubMed ID: 26791159
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pathways and Drugs in Pulmonary Arterial Hypertension - Focus on the Role of Endothelin Receptor Antagonists.
    Madonna R; Cocco N; De Caterina R
    Cardiovasc Drugs Ther; 2015; 29(5):469-79. PubMed ID: 26145170
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of children with pulmonary hypertension. Expert consensus statement on the diagnosis and treatment of paediatric pulmonary hypertension. The European Paediatric Pulmonary Vascular Disease Network, endorsed by ISHLT and DGPK.
    Hansmann G; Apitz C
    Heart; 2016 May; 102 Suppl 2():ii67-85. PubMed ID: 27053700
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pulmonary Arterial Hypertension: Pathophysiology and Treatment.
    Lan NSH; Massam BD; Kulkarni SS; Lang CC
    Diseases; 2018 May; 6(2):. PubMed ID: 29772649
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Endothelin receptor antagonists for pulmonary arterial hypertension.
    Liu C; Cheng J
    Cochrane Database Syst Rev; 2005 Jan; (1):CD004434. PubMed ID: 15674947
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Update: Preclinical developments for the treatment of pulmonary arterial hypertension].
    Janssen W; Ghofrani HA; Weissmann N; Grimminger F; Schermuly RT
    Dtsch Med Wochenschr; 2009 Aug; 134 Suppl 5():S157-9. PubMed ID: 19718604
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Macitentan for the treatment of pulmonary arterial hypertension.
    Hong IS; Coe HV; Catanzaro LM
    Ann Pharmacother; 2014 Apr; 48(4):538-47. PubMed ID: 24458948
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treating pulmonary hypertension in pediatrics.
    Lador F; Sekarski N; Beghetti M
    Expert Opin Pharmacother; 2015 Apr; 16(5):711-26. PubMed ID: 25665593
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.